JP2022535694A5 - - Google Patents
Info
- Publication number
- JP2022535694A5 JP2022535694A5 JP2021569057A JP2021569057A JP2022535694A5 JP 2022535694 A5 JP2022535694 A5 JP 2022535694A5 JP 2021569057 A JP2021569057 A JP 2021569057A JP 2021569057 A JP2021569057 A JP 2021569057A JP 2022535694 A5 JP2022535694 A5 JP 2022535694A5
- Authority
- JP
- Japan
- Prior art keywords
- extended
- release composition
- manufactured article
- use according
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962853153P | 2019-05-27 | 2019-05-27 | |
| US62/853,153 | 2019-05-27 | ||
| PCT/IB2020/054984 WO2020240417A1 (en) | 2019-05-27 | 2020-05-26 | Leuprolide acetate compositions and methods of using the same to treat breast cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535694A JP2022535694A (ja) | 2022-08-10 |
| JP2022535694A5 true JP2022535694A5 (cg-RX-API-DMAC7.html) | 2023-06-05 |
| JP7664855B2 JP7664855B2 (ja) | 2025-04-18 |
Family
ID=70922081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569057A Active JP7664855B2 (ja) | 2019-05-27 | 2020-05-26 | 乳がんを処置するためのリュープロリド酢酸塩組成物およびその使用方法 |
Country Status (17)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202112888RA (en) | 2019-05-27 | 2021-12-30 | Tolmar International Ltd | Leuprolide acetate compositions and methods of using the same to treat breast cancer |
| KR102742097B1 (ko) | 2020-12-23 | 2024-12-11 | 톨마 인터내셔날 리미티드 | 혼합 주사기 밸브 어셈블리를 위한 시스템 및 방법 |
| CN115518144A (zh) * | 2021-06-26 | 2022-12-27 | 王婧宜 | 一种含有亮丙瑞林或其衍生物的口服药物组合物 |
| USD1029245S1 (en) | 2022-06-22 | 2024-05-28 | Tolmar International Limited | Syringe connector |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5702716A (en) | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| US5324519A (en) | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| EP1125577B1 (en) | 1994-04-08 | 2006-02-15 | QLT USA, Inc. | Liquid drug delivery compositions |
| US6565874B1 (en) | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
| US8470359B2 (en) | 2000-11-13 | 2013-06-25 | Qlt Usa, Inc. | Sustained release polymer |
| CA2637569C (en) * | 2006-01-18 | 2013-01-08 | Yuhua Li | Pharmaceutical compositions with enhanced stability |
| EP3202814B1 (en) * | 2007-02-15 | 2019-10-16 | Tolmar Therapeutics, Inc. | Low burst poly-(lactide/glycolide) and methods to produce polymers |
| DE202009010095U1 (de) | 2009-07-24 | 2009-10-22 | Chang, Ti-Li, Houli | Verbindungsvorrichtung für einen auswechselbaren, abgeschlossenen Sekret-Absaugkatheter |
| HUE044352T2 (hu) * | 2011-10-14 | 2019-10-28 | Hoffmann La Roche | Pertuzumab, Trastuzumab, Docetaxel és Carboplatin korai stádiumú mellrák kezelésére |
| SG11202112888RA (en) | 2019-05-27 | 2021-12-30 | Tolmar International Ltd | Leuprolide acetate compositions and methods of using the same to treat breast cancer |
| KR102162217B1 (ko) | 2020-05-07 | 2020-10-06 | 주식회사 파인비엠 | 스태틱믹서를 갖는 연결장치를 구비한 시린지 결합 키트 |
| KR102742097B1 (ko) | 2020-12-23 | 2024-12-11 | 톨마 인터내셔날 리미티드 | 혼합 주사기 밸브 어셈블리를 위한 시스템 및 방법 |
| AU2022331238A1 (en) | 2021-08-19 | 2024-02-01 | Carefusion 303, Inc. | Pivc-integrated hemolysis-reduction accessories with anti-spillage component for direct blood draw |
| FR3131618A1 (fr) | 2021-12-30 | 2023-07-07 | Parker Hannifin Emea Sarl | Dispositif de raccordement aseptique d’un tube |
-
2020
- 2020-05-26 SG SG11202112888RA patent/SG11202112888RA/en unknown
- 2020-05-26 CA CA3141456A patent/CA3141456A1/en not_active Abandoned
- 2020-05-26 CN CN202080052698.5A patent/CN114144169A/zh active Pending
- 2020-05-26 PH PH1/2021/552976A patent/PH12021552976A1/en unknown
- 2020-05-26 EP EP20729830.8A patent/EP3975990A1/en active Pending
- 2020-05-26 BR BR112021023904A patent/BR112021023904A2/pt unknown
- 2020-05-26 US US17/614,312 patent/US12453754B2/en active Active
- 2020-05-26 KR KR1020217042734A patent/KR20220041782A/ko active Pending
- 2020-05-26 EA EA202193257A patent/EA202193257A1/ru unknown
- 2020-05-26 AU AU2020284587A patent/AU2020284587B2/en active Active
- 2020-05-26 JP JP2021569057A patent/JP7664855B2/ja active Active
- 2020-05-26 MX MX2021014540A patent/MX2021014540A/es unknown
- 2020-05-26 WO PCT/IB2020/054984 patent/WO2020240417A1/en not_active Ceased
- 2020-05-27 AR ARP200101496A patent/AR119021A1/es not_active Application Discontinuation
- 2020-05-27 TW TW109117742A patent/TWI757753B/zh active
- 2020-05-27 UY UY0001038717A patent/UY38717A/es not_active Application Discontinuation
-
2021
- 2021-11-28 IL IL288503A patent/IL288503A/en unknown
-
2025
- 2025-09-30 US US19/345,133 patent/US20260027176A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220354956A1 (en) | Biodegradable drug delivery for hydrophobic compositions | |
| AU2005251462B2 (en) | Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons | |
| CN103491946B (zh) | 可生物降解的药物释放组合物 | |
| EP1250138B2 (en) | Fulvestrant formulation | |
| CN102933201B (zh) | 抗真菌药物组合物 | |
| US20090325879A1 (en) | Controlled release copolymer formulation with improved release kinetics | |
| CN110201243A (zh) | 一种复合药物涂层球囊导管及其制备方法 | |
| CA2716576A1 (en) | Fulvestrant formulations | |
| KR102915096B1 (ko) | 연장 방출형 조성물을 이용한 중추성 성조숙증 어린이의 치료 방법 | |
| JP2022535694A (ja) | 乳がんを処置するためのリュープロリド酢酸塩組成物およびその使用方法 | |
| EP3821920A1 (en) | Combination for endoscopic surgery | |
| JP2024501166A (ja) | フルベストラントの徐放性医薬組成物及びその製造方法 | |
| CN116056687B (zh) | 含有mtor抑制剂的外用制剂 | |
| JP2023538265A (ja) | ホスホイノシチド3-キナーゼ阻害剤の製剤 | |
| CN101229150A (zh) | 含紫杉烷的温控缓释注射剂及其制备方法 | |
| JP2024511353A5 (cg-RX-API-DMAC7.html) | ||
| KR20230094172A (ko) | 용해도가 개선된 풀베스트란트의 약학 조성물 및 그 제조 방법 | |
| WO2003080181A2 (en) | Storage stable eplerenone formulation | |
| WO2024194781A1 (en) | Improved compositions | |
| KR20240105964A (ko) | 약동학적 특성이 우수한 풀베스트란트의 약학 조성물 및 그 제조 방법 | |
| KR20140147336A (ko) | 도세탁셀을 함유하는 액상 주사용 조성물 | |
| EP4422636A1 (en) | Inectable pharmaceutical composition for treatment of breast cancer | |
| KR20230079071A (ko) | 테스토스테론의 연장 전달을 위한 생분해성 폴리머 전달 시스템 | |
| HK1150021B (en) | Fulvestrant formulation |